Abstract
BackgroundSecukinumab has demonstrated improvement of signs and symptoms in RA patients in a phase 2 randomized controlled trial.1 In this analysis of the same study, we assessed the association between...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
